Cohen Joshua B — SEC Form 4 filings

SEC reporting owner CIK 1898644. 20 Form 4 filings on record with FilingPulse; latest filed 2026-09-14.

Transaction summary — filings shown

Covers all 20 filings on record, filed 2024-01-11 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amylyx Pharmaceuticals, Inc. (AMLX)Co-Chief Executive Officer, Director2016 legs · 325,033 sh · $4,417,97417

Form 4 filings — Cohen Joshua B

FiledFormIssuerReported transactionsSource
2026-09-144Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,545 @ $32.16 · Sale (S): 919 @ $33.15EDGAR
2026-08-204Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 60,039 @ $0EDGAR
2026-03-094Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 248,865 @ $0 · Grant/award (A): 373,295 (derivative) @ $0EDGAR
2026-03-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,282 @ $14.48EDGAR
2026-02-044Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 15,500 @ $14.68EDGAR
2026-01-204Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 197,182 @ $7.57 · Sale (S): 136,193 @ $13.59 · Option exercise (M): 2,818 @ $7.57 · Sale (S): 1,974 @ $13.83 · Option exercise (M): 197,182 (derivative) @ $0 · Option exercise (M): 2,818 (derivative) @ $0EDGAR
2026-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,715 @ $11.09EDGAR
2025-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 29,733 @ $14.34 · Sale (S): 200 @ $15.00EDGAR
2025-04-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 21,490 @ $3.47EDGAR
2025-03-104Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 180,118 @ $0 · Grant/award (A): 270,177 (derivative) @ $0EDGAR
2025-03-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,595 @ $3.17EDGAR
2025-02-054Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 11,851 @ $3.47EDGAR
2025-01-084Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 7,471 @ $4.05EDGAR
2024-10-024Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 18,589 @ $3.20EDGAR
2024-09-254Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 1,857 @ $1.57 · Option exercise (M): 1,857 (derivative) @ $0EDGAR
2024-09-164Amylyx Pharmaceuticals, Inc. (AMLX)Option exercise (M): 34,449 @ $1.57 · Option exercise (M): 34,449 (derivative) @ $0EDGAR
2024-04-184Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 179,850 @ $0 · Grant/award (A): 380,000 (derivative) @ $0EDGAR
2024-03-074Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 4,135 @ $18.73EDGAR
2024-02-284Amylyx Pharmaceuticals, Inc. (AMLX)Grant/award (A): 126,667 @ $0 · Grant/award (A): 190,000 (derivative) @ $0EDGAR
2024-01-114Amylyx Pharmaceuticals, Inc. (AMLX)Sale (S): 5,841 @ $16.33EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-10 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1898644 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →